Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
The Therapeutic Effect of Shirvan Herbal Ointment on Human Cutaneous Leishmaniasis Compared With Glucantime Publisher

Summary: Shirvan herbal ointment outperforms glucantime in reducing lesion size & treatment duration for cutaneous leishmaniasis. #Leishmaniasis #HerbalMedicine

M Aghaei MARYAM ; S Aghaei SHAHRZAD ; A Ghelichzadeh ALI ; N Ansari NAZLI ; M Fakhar MAHDI ; Sm Hosseini Sayed MOHSEN ; Z Shahmoradi ZABIHOLLAH ; Sh Hejazi Seyed HOSSEIN
Authors

Source: Advanced Biomedical Research Published:2024


Abstract

Background: Cutaneous leishmaniasis (CL) infection is caused by the Leishmania major (L. major) parasite and affects 1.5 to 2 million people worldwide each year. Although research into vaccines and antiparasitic drugs has been somewhat successful, their adverse effects include high toxicity, prolonged regeneration, and scarring. This has highlighted the importance of research to replace natural products with antibacterial and antioxidant properties, such as vegetable extracts and oils.Since, the anti-leishmaniasis effect of each of the components of Shirvan herbal ointment (aloe vera, Brazembel, Nigella sativa, propolis, lavender, and olive oil) has been separately studied and confirmed, it seems that the combination of these components can have an increasing anti-leishmanial effect to treat CL. Therefore, this study investigated the therapeutic impact of Shirvan herbal ointment on Iranian patients with leishmaniasis in comparison with glucantime (meglumine). Materials and Methods: Sixty patients with leishmaniasis were divided into the control and test groups. The control and test groups received intralesional glucantime and Shirvan herbal cream (two times daily), respectively. Results: The size mean of the lesion was 51.5 ± 32.5 before and 11.11 ± 16.28 after treatment in the control group and 50.8 ± 31.2 before and 0.0 ± 0.0 after treatment in the test group. In addition, the period mean of treatment was 43.9 ± 14.4 days and 30.5 ± 7.4 days in the control and test groups, respectively. There was a significant difference in lesion size between the two groups after treatment. Conclusion: Data suggested that Shirvan herbal ointment can be an alternative drug in the treatment of human CL. © 2025 Elsevier B.V., All rights reserved.
Related Docs
View other Related Docs
1. In Vitro Anti-Leishmanial Activity of Satureja Hortensis and Artemisia Dracunculus Extracts on Leishmania Major Promastigotes, Journal of Parasitic Diseases (2016)
2. Anti-Leishmanial Effects of Eryngium Planum and Ecbilliun Elaterum Methanolic Extract Against Leishmania Major, AMB Express (2024)
3. A Randomized, Placebo-Controlled Trial of a Two-Week Regimen of Aminosidine (Paromomycin) Ointment for Treatment of Cutaneous Leishmaniasis in Iran, American Journal of Tropical Medicine and Hygiene (1995)
Experts (# of related papers)
View all Related Experts
Ali Asilian (4)
Seyed Hossein Hejazi (3)
The Therapeutic Effect of Shirvan Herbal Ointment on Human Cutaneous Leishmaniasis Compared With Glucantime
Other Related Docs
4. Treatment of Cutaneous Leishmaniasis With Either Topical Paromomycin or Intralesional Meglumine Antimoniate, Clinical and Experimental Dermatology (2003)
5. Effect of Peel and Leaf Extract of Walnut (Juglans Regia L.) on Cutaneous Leishmaniasis Caused by Leishmania Major in Balb/C Mice, Journal of Chemical and Pharmaceutical Sciences (2016)
6. Treatment Role of Terpenoid Fraction of Perovskia Abrotanoides Kar. on Zoonotic Cutaneous Leishmaniasis in Animal Model, Traditional and Integrative Medicine (2022)
7. Comparing the Effects of Topical Miltefosine and Glucantime in Treatment of Cutaneous Leishmaniasis, Journal of Isfahan Medical School (2014)
8. The Effects of Prednisolone and Mometasone on Wound Healing Caused by Leishmania Major in Balb/C Mice, Journal of Isfahan Medical School (2020)
9. Comparision Effectivness of Extracts of Thyme, Yarrow, Henna and Garlic on Cutaneous Leishmaniasis Caused by L. Major in Animal Model (Balb/C), Journal of Medicinal Plants (2009)
10. Comparison Between the Efficacy of Photodynamic Therapy and Topical Paromomycin in the Treatment of Old World Cutaneous Leishmaniasis: A Placebo-Controlled, Randomized Clinical Trial, Clinical and Experimental Dermatology (2006)
11. Treatment of Recurrent Cutaneous Leishmaniasis, International Journal of Dermatology (1995)
12. A Comparison of the Effects of Topical Injection of Glucantime Plus Glycolic Acid 70% and Salicylic Acid 20% With Topical Injection of Glucantime Alone in the Treatment of Acute Cutaneous Leishmaniasis, Journal of Isfahan Medical School (2017)
13. The Efficacy of Intralesional Meglumine Antimoniate (Glucantime) Versus a Combination of Topical Trichloroacetic Acid 50% and Local Heat Therapy by Non-Ablative Radiofrequency on Cutaneous Leishmaniasis Lesions, Journal of Isfahan Medical School (2012)
14. Comparison Between the Efficacy of Photodynamic Therapy and Topical Paromomycin in the Treatment of Old World Cutaneous Leishmaniasis: A Placebo-Controlled, Randomized Clinical Trial, Indian Journal of Dermatology (2006)
15. Topical Effectiveness of Different Concentrations of Nanosilver Solution on Leishmania Major Lesions in Mice (Balb/C), Journal of Isfahan Medical School (2011)
16. The Efficacy of Achillea Millefolium Topical Gel Along With Intralesional Injection of Glucantime in the Treatment of Acute Cutaneous Leishmaniasis, Journal of Isfahan Medical School (2012)
17. Antimonial Treatment Failure Rate in Patients With Cutaneous Leishmaniasis, Tehran University Medical Journal (2018)
18. Efficacy of Paromomycin Ointment in the Treatment of Cutaneous Leishmaniasis: Results of a Double-Blind, Randomized Trial in Isfahan, Iran, Annals of Tropical Medicine and Parasitology (2005)
19. Effect of Combination Therapy With Systemic Glucantime and Pentoxifylline in the Treatment of Cutaneous Leishmaniasis, International Journal of Dermatology (2006)
20. A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Itraconazole in the Treatment of Cutaneous Leishmaniasis, Journal of the European Academy of Dermatology and Venereology (2005)